Medical network - March 20 knowin drug prices in pk.
▍ documents released in June
Learned from the people close to the decision makers that continue to brewing a year's drugs ex-factory price information traceability, has confirmed that will be issued in June this year.
According to the previous plan, this turn, led by the state administration of food drug safety interagency collaboration, will establish a unified price information platform across departments, prepare and drug centralized purchasing platform (public resources trading platform), medical insurance payment platform, interconnection, and strengthen with the relevant tax data sharing.
"The current price streaking across the country only a few provinces such as fujian, jiangsu, once the traceability system was established, the national price information network with tender, health care, taxation, the impact on the enterprise is very big, this is an important means state equilibrium prices." Yesterday, a pharmaceutical industry to match the blue parker said.
In August 2016, the market adjusted drug price behavior in jiangsu province ", this is the first domestic provinces to develop such rules.
In jiangsu rules, the market adjusted drugs form, the price of drugs prices cost accounting form, drug operators to follow the principle of were file clear - except anesthesia, such as pricing by the government, the psychotropic drugs of category I drug prices for market regulation, drug business operators shall, in accordance with the accounting standards for enterprises ", "enterprise financial rules", such as specifications, combined with specific drug prices in the "rules" major project cost, accounting during drug manufacturing costs, expenses, profit, etc., comprehensive factors such as market supply and demand, market price of similar species independently work out the price.
And control cost pricing, is from the original drug prices back to establish the main goal.
October 6, 2016, li keqiang, on a state council executive meeting on April 6, made it clear that "reform has entered into deep waters, measures must be taken to overcome the difficulties, to" price "as a breakthrough." He stressed that will accelerate the establishment of a mechanism traceability drug prices. On the one hand tracking management, to ensure drug quality; On the other hand to promote drug price information, make the drug prices "transparent". Li clear requirements relevant departments, "this question can't again just" research study ", to accelerate the!"
Finally, prime minister li keqiang said, to "price" as the breakthrough point, lower drug prices, improve the performance salary system of medical institutions, which reversed transmission mechanism reform of public hospitals and medicine circulation system reform, to promote the further development of medical and health system reform.
▍ domestic drug firms under pressure
And there is no doubt that this system will be the first to reverberate domestic companies.
On February 9, 2017, issued by the general office of the state council concerning the further reform and improve the use policy for producing and distributing medicines of several opinions, again clear written drug prices the traceability system.
"The drug price monitoring system, and promote the drugs market price transparency. The food and drug regulators led start drugs ex-factory price information traceability mechanism, establish a unified platform for the inter-departmental price information, prepare and drug centralized purchasing platform (public resources trading platform), medical insurance payment platform, interconnection, strengthen with the relevant tax data sharing." File is emphasized.
File at the same time stressed that "to inflate the price of raw materials and pharmaceutical factory price of drug manufacturers, prices, food and drug supervision, taxation and other departments to investigate in accordance with the law, pay taxes receivable, shall be investigated for the responsibility of the relevant responsible persons. Strengthen the insufficient competition pharmaceutical factory (port) price, the actual purchasing and selling price monitoring, the abnormal price changes or with varieties of drugs price difference is too high, should be timely research and analysis, when it is necessary to carry out the cost price of special investigation."
Had a view, as long as the tax invoice system upgrades, drug price associated with the code in the traceability system, eventually realize the drugs ex-factory price tracing system "who wanted a yard" function; And multinational pharmaceutical companies because of the production line is not in the home, the whole drug production costs are still unable to fully acquisition, in contrast, domestic drug firms huge pressure.
In camp today, instead of two votes, against the background of docking drug prices back again if monitoring platform system, drug prices to achieve relatively transparent has no barriers, domestic production enterprises of production costs, profits, costs can be financial calculation and audit, to every link of enterprise marketing and cost control, profit how will release pressure will become the most imminent local drug firms. |
